Concomitant reduction of body weight and HbA1C effectively lowers mortality risk in type 2 diabetes: Study Medha Baranwal5 Dec 2023 11:45 AM ISTFrance: Concomitant reductions in body weight and glycated haemoglobin (HbA1c) are more effective in preventing the risk of mortality and vascular...
Fat-to-muscle ratio linked with insulin resistance in adults with type 1 diabetes Medha Baranwal16 Nov 2023 10:00 AM ISTChina: Fat-to-muscle ratio (FMR) is associated with cardiometabolic disorders (CMD) and insulin resistance (IR) in patients with type 1 diabetes...
Earlier Onset of Puberty on the rise among Children with Type 1 Diabetes Jacinthlyn Sylvia20 Oct 2023 9:15 AM ISTA recent study conducted by the German Diabetes Prospective Follow-up (DPV) registry found the trends and factors associated with the onset of puberty...
Can semaglutide and empagliflozin combo lower albuminuria in patients with type 2 diabetes? Medha Baranwal30 Sept 2023 11:45 AM ISTDenmark: A randomized and placebo-controlled study investigated the albuminuria-lowering effect of semaglutide addition on top of empagliflozin in...
DPP4 inhibitor cetagliptin effective and well-tolerated for treating patients with type 2 diabetes Medha Baranwal27 Sept 2023 11:45 AM ISTChina: A randomized double-blind, placebo-controlled phase 3 trial has shed light on the safety and efficacy of cetagliptin as monotherapy in patients...
Anti-CD3 monoclonal antibodies promising for treating recent-onset type 1 diabetes Dr. Kamal Kant Kohli1 Sept 2023 11:45 AM ISTPakistan: A recent review published in Diabetes, Obesity and Metabolism has shown anti-CD3 monoclonal antibodies to be a viable treatment portion for...
Dorzagliatin treatment associated with diabetes remission in drug naive patients with type 2 diabetes Dr. Kamal Kant Kohli19 July 2023 11:30 AM ISTChina: Dorzagliatin treatment leads to drug-free diabetes remission and stable glycemic control in people with type 2 diabetes (T2D) who have not yet...
Dapagliflozin, a feasible alternative to sulphonylureas as an add-on after metformin failure in type 2 diabetes patients Medha Baranwal24 Jun 2023 11:15 AM ISTKorea: Dapagliflozin is safe and well-tolerated and, therefore, appears to be a more favourable alternative to sulphonylureas as an add-on therapy...
High glycated albumin levels tied to risk of CVD and death in advanced-stage diabetic kidney disease patients Medha Baranwal22 Jun 2023 10:00 AM ISTChina: A meta-analysis published in Diabetes, Obesity and Metabolism has shown an association between high glycated albumin (GA) and an increased risk...
Real-world data reveals remission rate of type 2 diabetes to be 1 in 100 patients Dr. Kamal Kant Kohli16 Jun 2023 10:00 AM ISTJapan: A recent study published in Diabetes, Obesity and Metabolism revealed a greater difference in remission (of type 2 diabetes) incidence and...
Orlistat mouth rinse effectively lowers total and fat calorie intake in obese individuals Jacinthlyn Sylvia23 May 2023 10:00 AM ISTA new study published in the Journal of Diabetes Obesity and Metabolism found that, Orlistat mouth rinse may be an effective alternative in...
Astaxanthin lowers cholesterol and CVD risk in people with prediabetes and dyslipidemia Medha Baranwal6 April 2023 11:30 AM ISTUSA: A recent study published in Diabetes, Obesity and Metabolism has shown that astaxanthin, a natural antioxidant is a safe over-the-counter (OTC)...
